Boscaro M - Search Results

1

Estrogen and thyroid cancer is a stem affair: A preliminary study.

Zane M, Parello C, Pennelli G, Townsend DM, Merigliano S, Boscaro M, Toniato A, Baggio G, Pelizzo MR, Rubello D, Boschin IM. Zane M, et al. Among authors: boscaro m. Biomed Pharmacother. 2017 Jan;85:399-411. doi: 10.1016/j.biopha.2016.11.043. Epub 2016 Nov 26. Biomed Pharmacother. 2017. PMID: 27899250 Free PMC article.

2

Acute and chronic effects of high glucocorticoid levels on hypothalamic-pituitary-thyroid axis in man.

Rubello D, Sonino N, Casara D, Girelli ME, Busnardo B, Boscaro M. Rubello D, et al. Among authors: boscaro m. J Endocrinol Invest. 1992 Jun;15(6):437-41. doi: 10.1007/BF03348767. J Endocrinol Invest. 1992. PMID: 1328349

3

The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways.

Barollo S, Bertazza L, Baldini E, Ulisse S, Cavedon E, Boscaro M, Pezzani R, Mian C. Barollo S, et al. Among authors: boscaro m. Invest New Drugs. 2014 Aug;32(4):626-35. doi: 10.1007/s10637-014-0108-3. Epub 2014 May 13. Invest New Drugs. 2014. PMID: 24821574

4

Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells.

Bertazza L, Barollo S, Radu CM, Cavedon E, Simioni P, Faggian D, Plebani M, Pelizzo MR, Rubin B, Boscaro M, Pezzani R, Mian C. Bertazza L, et al. Among authors: boscaro m. J Cell Mol Med. 2015 Sep;19(9):2244-52. doi: 10.1111/jcmm.12612. Epub 2015 Jun 17. J Cell Mol Med. 2015. PMID: 26081844 Free PMC article.

5

A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC.

Occhi G, Barollo S, Regazzo D, Bertazza L, Galuppini F, Guzzardo V, Jaffrain-Rea ML, Vianello F, Ciato D, Ceccato F, Watutantrige-Fernando S, Bisognin A, Bortoluzzi S, Pennelli G, Boscaro M, Scaroni C, Mian C. Occhi G, et al. Among authors: boscaro m. Oncotarget. 2015 Oct 13;6(31):32104-14. doi: 10.18632/oncotarget.5194. Oncotarget. 2015. PMID: 26392334 Free PMC article.

6

Paclitaxel is an effective antiproliferative agent on the human NCI-H295 adrenocortical carcinoma cell line.

Fallo F, Pilon C, Barzon L, Pistorello M, Pagotto U, Altavilla G, Boscaro M, Sonino N. Fallo F, et al. Among authors: boscaro m. Chemotherapy. 1998 Mar-Apr;44(2):129-34. doi: 10.1159/000007104. Chemotherapy. 1998. PMID: 9551244

7

Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase.

Barzon L, Bonaguro R, Castagliuolo I, Chilosi M, Franchin E, Del Vecchio C, Giaretta I, Boscaro M, Palù G. Barzon L, et al. Among authors: boscaro m. Eur J Endocrinol. 2003 Jan;148(1):73-80. doi: 10.1530/eje.0.1480073. Eur J Endocrinol. 2003. PMID: 12534360

8

Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma.

Barzon L, Gnatta E, Castagliuolo I, Trevisan M, Moretti F, Pontecorvi A, Boscaro M, Palù G. Barzon L, et al. Among authors: boscaro m. Cancer Gene Ther. 2005 Apr;12(4):381-8. doi: 10.1038/sj.cgt.7700789. Cancer Gene Ther. 2005. PMID: 15650765

9

Effects of taxol on the human NCI-H295 adrenocortical carcinoma cell line.

Fallo F, Pilon C, Barzon L, Pistorello M, Pagotto U, Altavilla G, Boscaro M, Sonino N. Fallo F, et al. Among authors: boscaro m. Endocr Res. 1996 Nov;22(4):709-15. doi: 10.1080/07435809609043766. Endocr Res. 1996. PMID: 8969931

10

Gene therapy for thyroid cancer.

Barzon L, Pacenti M, Boscaro M, Palù G. Barzon L, et al. Among authors: boscaro m. Expert Opin Biol Ther. 2004 Aug;4(8):1225-39. doi: 10.1517/14712598.4.8.1225. Expert Opin Biol Ther. 2004. PMID: 15268658 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters